Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Clinical & Experimental Metastasis
|
July 15, 2003
Phospholipase C-gamma1 in tumor progression
Alan Wells, Jennifer Rubin Grandis
Anti-Cancer Drugs
|
December 24, 2010
New advances in molecular approaches to head and neck squamous cell carcinoma
Nivedita Sahu, Jennifer Rubin Grandis
Head & Neck
|
December 13, 2002
Targeting epidermal growth factor receptor in head and neck cancer
Allison Carter Ford, Jennifer Rubin Grandis
Pharmacology & Therapeutics
|
April 2, 2004
Signaling through the epidermal growth factor receptor during the development of malignancy
Jennifer Rubin Grandis, John C Sok
Journal of Oncology
|
July 29, 2009
Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors
Ann Marie Egloff, Jennifer Rubin Grandis
Human Gene Therapy
|
September 15, 2009
The current state of head and neck cancer gene therapy
Sufi Mary Thomas, Jennifer Rubin Grandis
Current Oncology Reports
|
February 14, 2003
The role of epidermal growth factor receptor in head and neck squamous cell carcinoma
Rebecca G Pomerantz, Jennifer Rubin Grandis
Current Pharmaceutical Design
|
August 17, 2005
Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond
Francesca Marietta Coppelli, Jennifer Rubin Grandis
Current Treatment Options in Oncology
|
December 14, 2005
Advances in molecular diagnostics and therapeutics in head and neck cancer
Raymond Liu Chai, Jennifer Rubin Grandis
Seminars in Oncology
|
December 16, 2004
The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy
Rebecca G Pomerantz, Jennifer Rubin Grandis
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Clinical & Experimental Metastasis
|
July 15, 2003
Phospholipase C-gamma1 in tumor progression
Alan Wells, Jennifer Rubin Grandis
Anti-Cancer Drugs
|
December 24, 2010
New advances in molecular approaches to head and neck squamous cell carcinoma
Nivedita Sahu, Jennifer Rubin Grandis
Head & Neck
|
December 13, 2002
Targeting epidermal growth factor receptor in head and neck cancer
Allison Carter Ford, Jennifer Rubin Grandis
Pharmacology & Therapeutics
|
April 2, 2004
Signaling through the epidermal growth factor receptor during the development of malignancy
Jennifer Rubin Grandis, John C Sok
Journal of Oncology
|
July 29, 2009
Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors
Ann Marie Egloff, Jennifer Rubin Grandis
Human Gene Therapy
|
September 15, 2009
The current state of head and neck cancer gene therapy
Sufi Mary Thomas, Jennifer Rubin Grandis
Current Oncology Reports
|
February 14, 2003
The role of epidermal growth factor receptor in head and neck squamous cell carcinoma
Rebecca G Pomerantz, Jennifer Rubin Grandis
Current Pharmaceutical Design
|
August 17, 2005
Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond
Francesca Marietta Coppelli, Jennifer Rubin Grandis
Current Treatment Options in Oncology
|
December 14, 2005
Advances in molecular diagnostics and therapeutics in head and neck cancer
Raymond Liu Chai, Jennifer Rubin Grandis
Seminars in Oncology
|
December 16, 2004
The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy
Rebecca G Pomerantz, Jennifer Rubin Grandis
Page
of 6